Business / 23andMe / GSK

Why GSK just made a $300 million bet on 23andMe's approach to finding new medicines

Posted on: Jul 25, 2018   |   Posted by: Travel Mag

Why GSK just made a $300 million bet on 23andMe's approach to finding new medicines

Getty Images/Kimberly White Consumer genetics company 23andMe is teaming up with UK drug giant GlaxoSmithKline to develop new drugs. As part of the four-year collaboration, GSK...

Continue reading ...



Other Posts from Travel Mag